(HALO) Halozyme Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Halozyme Therapeutics | (HALO) share price targets
Complete technical analysis of Halozyme Therapeutics (HALO) by charts plus indicators, forecast predictions and share price targets for Halozyme Therapeutics (HALO)
Halozyme Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-03-22 View latest technical analysis
10 day averaged volume of Halozyme Therapeutics is 1084610
Date | Daily Closing Price | Open | High | Low | Volume |
22 Fri Mar 2024 | 40.08 | 40.30 | 41.03 | 40.04 | 0.733 times |
21 Thu Mar 2024 | 40.22 | 40.69 | 42.30 | 40.12 | 0.856 times |
20 Wed Mar 2024 | 40.38 | 40.52 | 40.58 | 39.69 | 0.772 times |
19 Tue Mar 2024 | 40.81 | 40.46 | 41.33 | 40.46 | 0.782 times |
18 Mon Mar 2024 | 40.37 | 40.93 | 40.96 | 40.32 | 0.965 times |
15 Fri Mar 2024 | 40.86 | 40.56 | 41.48 | 40.56 | 1.684 times |
14 Thu Mar 2024 | 40.79 | 41.08 | 41.31 | 39.94 | 1.381 times |
13 Wed Mar 2024 | 41.35 | 42.13 | 42.64 | 41.14 | 1.089 times |
12 Tue Mar 2024 | 41.95 | 41.55 | 42.12 | 41.28 | 0.889 times |
11 Mon Mar 2024 | 41.20 | 41.61 | 42.25 | 40.95 | 0.797 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 40.1, but if it comes above 40.1, then a intra day buy could be more profitable.
If you take a sell trade below 40.1, then use 40.1 as stoploss and 39.2 as target. However if you take a buy trade in stock , then use 40.1 as stoploss and 40.78 as target.
Share price targets for Halozyme Therapeutics (HALO)
Target Type | Value |
Downside Target | 33.10 |
Downside Target | 35.50 |
Downside Target | 38.29 |
Upside Target | 40.95 |
Upside Target | 41.09 |
Upside Target | 41.86 |
Upside Target | 42.30 |
Upside Target | 42.52 |
Upside Target | 42.64 |
Upside Target | 42.82 |
Intraday share price targets for Halozyme Therapeutics (HALO)
Target Type | Value |
Downside Intraday Target | 39.08 |
Downside Intraday Target | 38.08 |
Upside Intraday Target | 41.69 |
Upside Intraday Target | 43.3 |
Upside Intraday Target | 40.69 |
Weekly technical analysis of Halozyme Therapeutics (HALO)
Date | Weekly Closing Price | Open | High | Low | Volume |
22 Fri Mar 2024 | 40.08 | 40.93 | 42.30 | 39.69 | 0.703 times |
15 Fri Mar 2024 | 40.86 | 41.61 | 42.64 | 39.94 | 1.423 times |
08 Fri Mar 2024 | 41.73 | 41.33 | 42.52 | 40.46 | 0.697 times |
01 Fri Mar 2024 | 41.11 | 40.40 | 41.86 | 38.96 | 0.917 times |
23 Fri Feb 2024 | 40.56 | 35.70 | 40.95 | 35.50 | 1.432 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Halozyme Therapeutics (HALO)
Date | Monthly Closing Price | Open | High | Low | Volume |
22 Fri Mar 2024 | 40.08 | 40.00 | 42.64 | 39.69 | 0.676 times |
29 Thu Feb 2024 | 39.81 | 33.88 | 40.95 | 33.15 | 0.609 times |
31 Wed Jan 2024 | 33.85 | 36.83 | 38.29 | 33.67 | 1.798 times |
29 Fri Dec 2023 | 36.96 | 38.81 | 42.82 | 35.78 | 0.981 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Halozyme Therapeutics (HALO)
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term but the sell signal is initial and weak.
Halozyme Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 40.83 and Halozyme Therapeutics (HALO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term but the sell signal is initial and weak.
Halozyme Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 40.83 and Halozyme Therapeutics (HALO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.